A decision on whether to extend emergency use of the Pfizer/BioNTech Covid-19 vaccine to people ages 12 to 15 could be made in “a couple of weeks,” Dr. Peter Marks, director of the US Food and Drug Administration's Center for Biologics Evaluation and Research, said Tuesday.
Pfizer recently asked the FDA to expand the emergency use authorization of the vaccine to include people ages 12 to 15 years.
“Obviously we feel a sense of urgency of getting through these, and we'll do our best to be reviewing this,” Marks said in a webinar hosted by the American Medical Association. “If we can get down to age 12, we can get junior high and high school kids with a good vaccination campaign back to school, hopefully in the fall.”
Right now, the emergency use authorization for the Pfizer vaccine is for people 16 and older.